Skip to main content
. 2022 Apr 3;10(4):556. doi: 10.3390/vaccines10040556

Table 4.

QuantiFERON-SARS-CoV-2 positivity before and after CoronaVac and BNT162b2 booster.

CoronaVac Group (n = 74) BNT162b2 Group (n = 104) p-Value 1
Positive at baseline 33.8 % (25/74) 30.8% (32/104) p = 0.9582
Positive at day 30 63.5% (47/74) 86.5% (90/104) p < 0.0001

1 p-values were tested using Mann-Whitney test.